How does larotrectinib work?
Larotrectinibis used to treat solid tumors (cancers) caused by certain abnormalities in the NTRK gene that have spread, or where surgery to remove the cancer may cause serious complications and there are no acceptable treatment options or the cancer has grown or spread during other treatments.

Larotrectinibis a targeted drug called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that cells use to send signals to each other to grow. They act as chemical messengers. Blocking these signals can help slow or stop the development of cancer. There are several different tyrosine kinases, Before receiving treatment, patients need to have their cancer cells tested, tests look for changes in these proteins or genes, and tests for the NTRK gene.
Larotrectinib is a kinase inhibitor. Larotrectinibcapsules and oral solutions are formulated using larotrectinibsulfate. The molecular formula of larotinib sulfate isC21H24F2N6O6The molecular weight of sulfate is526.51g/ moles, the molecular weight of the free base is 428.44 grams/ moles. The chemical name is (3S)-N-{5-[(2R)-2-(
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)